Thrombosis is the most common cause of vascular access dysfunction. Missed hemodialysis sessions significantly increase the number of thrombosis episodes in AVFs and AVGs. HeRO Graft thrombosis rates are comparable to conventional grafts and are treated with similar methods.
- Test for coagulability disorders after repeated clotting episodes.
- After a clotting episode, thoroughly image the inflow artery all the way to the shoulder and throughout the entire HeRO Graft, including the Venous Outflow Component tip, to identify the root causes.
- Consider prescribing an anticoagulant in patients with repeated clotting episodes.
- During dialysis treatment, closely monitor the patient for hypotensive events. A clinical evaluation of prescribed hypertensive medication may be necessary.
- Avoid using fistula clamps after a dialysis session.
Contact Customer Service at 888-427-9654 with device-related or technical questions and tell us about your experience by using our Contact Us form.
The HeRO Graft is intended for use in maintaining long-term vascular access for chronic hemodialysis patients who have exhausted peripheral venous access sites suitable for fistulas or grafts. See the Instructions for Use manual for full prescribing information.
13-0025 Rev. E